Hepatoprotective potential of Aloe vera polysaccharides against chronic alcohol-induced hepatotoxicity in mice

J Sci Food Agric. 2014 Jul;94(9):1764-71. doi: 10.1002/jsfa.6489. Epub 2014 Jan 2.

Abstract

Background: Aloe vera polysaccharides are reported to exhibit multiple biological effects, including anti-oxidation, anti-inflammation and immune enhancement. However, their influence on alcoholic liver disease (ALD) remains unclear. This study was designed to determine the protective effect of extracted A. vera polysaccharides (AVGP) against ALD in a chronic alcohol-feeding mouse model and investigate the possible underlying mechanisms.

Results: Supplementation of AVGP significantly attenuated the levels of serum aminotransferases, lipids and hepatic TG and ameliorated histopathological alterations in the model of ALD. Interestingly, AVGP markedly up-regulated hepatic expression of lipolytic genes (AMPK-α2 and PPAR-α) but had no effect on lipogenic gene expression. AVGP diminished alcohol-dependent oxidative stress partly through a decrease in MDA and increase in GSH and SOD. Alcohol-induced inflammation was also mitigated by AVGP treatment via significant reduction in LPS and TNF-α, down-regulation of TLR-4 and MyD88 and up-regulation of IκB-α.

Conclusion: This study clearly showed that AVGP exerts a potent protective effect against chronic alcohol-induced liver injury. Its hepatoprotective effect appears to be associated with its antioxidant capacity and its ability to accelerate lipolysis and inhibit inflammatory response. The results indicate that AVGP could be considered as a potent food supplement in the prevention of ALD.

Keywords: Aloe vera polysaccharides; chronic alcoholic liver injury; hepatoprotective; inflammation; lipid accumulation; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Aloe / chemistry*
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Chemical and Drug Induced Liver Injury / metabolism
  • Chemical and Drug Induced Liver Injury / pathology
  • Chemical and Drug Induced Liver Injury / prevention & control*
  • Disease Models, Animal
  • Ethanol / adverse effects*
  • I-kappa B Proteins / metabolism
  • Lipid Metabolism / drug effects
  • Liver / drug effects*
  • Liver / metabolism
  • Liver / pathology
  • Liver Diseases, Alcoholic / metabolism
  • Liver Diseases, Alcoholic / pathology
  • Liver Diseases, Alcoholic / prevention & control*
  • Male
  • Malondialdehyde / metabolism
  • Mice
  • NF-KappaB Inhibitor alpha
  • PPAR gamma / metabolism
  • Phytotherapy*
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Polysaccharides / pharmacology
  • Polysaccharides / therapeutic use*
  • Toll-Like Receptor 4 / metabolism
  • Transaminases / blood
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • I-kappa B Proteins
  • Nfkbia protein, mouse
  • PPAR gamma
  • Plant Extracts
  • Polysaccharides
  • Toll-Like Receptor 4
  • Tumor Necrosis Factor-alpha
  • NF-KappaB Inhibitor alpha
  • Ethanol
  • Malondialdehyde
  • Transaminases
  • AMPK alpha2 subunit, mouse
  • AMP-Activated Protein Kinases